Clinical Trial Update: Efficacy and Safety of Circadin® in the Treatment of Sleep Disturbances in Children With Neurodevelopment Disabilities [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of Circadin for sleep disturbances in children with neurodevelopmental disabilities completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurodevelopmental Disorders
• Sleep Disorders

Drugs mentioned

• Circadin (melatonin)

Snippet

Sponsor: Neurim Pharmaceuticals Ltd. | Conditions: Sleep Disorders | Phase 3 | Status: COMPLETED | Results posted: 2018-10-30